Selective nanoparticle adhesion can enhance colitis therapy

One of the major challenges in IBD therapy is targeting delivery of the drug to the specific site of inflammation. A recent approach to combat this problem is the use of nanoparticulate drug

delivery systems that selectively accumulate a given drug at the site of affected tissue. As the drug load is delivered locally, drug dose and adverse effects are reduced. Access through

your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12

print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be

subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support

REFERENCES * Laroui, H. _ et al_. Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model. _Gastroenterology_ 138, 843–853 (2010).

Article  CAS  PubMed  Google Scholar  * Lamprecht, A. _ et al_. Biodegradable nanoparticles for the targeted drug delivery in the treatment of inflammatory bowel disease. _J. Pharmacol. Exp.

Ther._ 299, 775–781 (2001). CAS  PubMed  Google Scholar  * Nakase, H. _ et al_. An oral drug delivery system targeting immune-regulating cells ameliorates mucosal injury in trinitrobenzene

sulfonic acid-induced colitis. _J. Pharmacol. Exp. Ther._ 297, 1122–1128 (2001). CAS  PubMed  Google Scholar  * Hassani, S., Pellequer, Y. & Lamprecht, A. Selective adhesion of

nanoparticles to inflamed tissue in gastric ulcers. _Pharm. Res._ 26, 1149–1154 (2009). Article  PubMed  Google Scholar  * Pellequer, Y., Meissner, Y., Ubrich, N. & Lamprecht, A.

Epithelial heparin delivery via microspheres mitigates experimental colitis in mice. _J. Pharmacol. Exp. Ther._ 321, 726–733 (2007). Article  CAS  PubMed  Google Scholar  * Farrell, R. J. _

et al_. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. _Gastroenterology_ 118, 279–288 (2000). Article  CAS 

PubMed  Google Scholar  * Pastorelli, L. _ et al_. Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate

left-sided ulcerative colitis. _Aliment. Pharmacol. Ther._ 28, 581–588 (2008). Article  CAS  PubMed  Google Scholar  * Cho, K., Wang, X., Nie, S., Chen, Z. G. & Shin, D. M. Therapeutic

nanoparticles for drug delivery in cancer. _Clin. Cancer Res._ 14, 1310–1316 (2008). Article  CAS  PubMed  Google Scholar  * Lamprecht, A., Yamamoto, H., Takeuchi, H. & Kawashima, Y.

Nanoparticles enhance therapeutic efficiency by selectively increased local drug dose in experimental colitis in rats. _J. Pharmacol. Exp. Ther._ 315, 196–202 (2005). Article  CAS  PubMed 

Google Scholar  * Tirosh, B., Khatib, N., Barenholz, Y., Nissan, A. & Rubinstein, A. Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa.

_Mol. Pharm._ 6, 1083–1091 (2009). Article  CAS  PubMed  Google Scholar  * Moulari, B., Pertuit, D., Pellquer, Y. & Lamprecht, A. The targeting of surface modified silica nanoparticles

to inflamed tissue in experimental colitis. _Biomaterials_ 29, 4554–4560 (2008). Article  CAS  PubMed  Google Scholar  * Lamprecht, A., Yamamoto, H., Takeuchi, H. & Kawashima, Y. A

pH-sensitive microsphere system for the colon delivery of tacrolimus containing nanoparticles. _J. Control. Rel._ 104, 337–346 (2005). Article  CAS  Google Scholar  Download references

AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Pharmaceutical Engineering, Institute of Pharmacy, University of Bonn, Gerhard-Dogmak-Strasse 3, Bonn, Germany Alf Lamprecht

Authors * Alf Lamprecht View author publications You can also search for this author inPubMed Google Scholar ETHICS DECLARATIONS COMPETING INTERESTS The author declares no competing

financial interests. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Lamprecht, A. Selective nanoparticle adhesion can enhance colitis therapy. _Nat Rev

Gastroenterol Hepatol_ 7, 311–312 (2010). https://doi.org/10.1038/nrgastro.2010.66 Download citation * Issue Date: June 2010 * DOI: https://doi.org/10.1038/nrgastro.2010.66 SHARE THIS

ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard

Provided by the Springer Nature SharedIt content-sharing initiative